Eubel Brady & Suttman Asset Management’s Amgen AMGN Stock Holding History

Eubel Brady & Suttman Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.3M	Sell	3,710 -583	-14%	-$208K	0.15%	55
2025 Q4	$1.41M	Sell	4,293 -123	-3%	-$39K	0.16%	52
2025 Q3	$1.25M	Buy	+4,416	New	+$1.28M	0.14%	52
2021 Q3	–	Sell	-355	Closed	-$88K	–	83
2021 Q2	$88K	Buy	+355	New	+$87.3K	0.01%	266
2020 Q1	–	Sell	-12,409	Closed	-$98K	–	74
2019 Q4	$98K	Buy	+12,409	New	+$2.74M	0.03%	73

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Eubel Brady & Suttman Asset Management's AMGN Position: Q1 2026 in Review

Eubel Brady & Suttman Asset Management reduced its Amgen (AMGN) stake by 14% in Q1 2026, selling an estimated $208K and leaving 3,710 shares worth $1.3M. The position accounts for 0.15% of the portfolio, ranked #55.

Eubel Brady & Suttman Asset Management first reported a position in AMGN in Q4 2019 and has held it in 5 quarters since. The position peaked at $1.41M in Q4 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Eubel Brady & Suttman Asset Management held 3,710 shares of Amgen worth $1.3M as of Q1 2026.
Eubel Brady & Suttman Asset Management sold 583 Amgen shares in Q1 2026, an estimated $208K.
Amgen made up 0.15% of Eubel Brady & Suttman Asset Management's portfolio in Q1 2026, its #55 holding.
Eubel Brady & Suttman Asset Management first reported a position in Amgen in Q4 2019 and has held it in 5 quarters since.
Eubel Brady & Suttman Asset Management's Amgen position peaked at $1.41M in Q4 2025.
3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Eubel Brady & Suttman Asset Management's 13F filing for Q1 2026, filed 11 May 2026.